Similar articles

• [The effectiveness of sex hormone replacement therapy in male hypogonadism].

  Butrova SA, Kogan BS. Butrova SA, et al. Probl Endokrinol (Mosk). 1971 Sep-Oct;17(5):43-7. Probl Endokrinol (Mosk). 1971. PMID: 5148296 Russian. No abstract available.
• Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.

  Ozata M, Bulur M, Beyhan Z, Sengül A, Saglam M, Turan M, Corakci A, Ali Gundogan M. Ozata M, et al. Endocr J. 1997 Oct;44(5):719-24. doi: 10.1507/endocrj.44.719. Endocr J. 1997. PMID: 9466329
• Klinefelter's syndrome: examination of thyroid function, and the TSH and PRL responses to thyrotropin-releasing hormone prior to and after testosterone administration.

  Burman KD, Dimond RC, Noel GL, Earll JM, Frantz AG, Wartofsky L. Burman KD, et al. J Clin Endocrinol Metab. 1975 Dec;41(06):1161-6. doi: 10.1210/jcem-41-6-1161. J Clin Endocrinol Metab. 1975. PMID: 812883
• Klinefelter Syndrome and medical treatment: hypogonadism and beyond.

  Chang S, Skakkebæk A, Gravholt CH. Chang S, et al. Hormones (Athens). 2015 Oct-Dec;14(4):531-48. doi: 10.14310/horm.2002.1622. Hormones (Athens). 2015. PMID: 26732150 Review.
• Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition.

  Bojesen A, Høst C, Gravholt CH. Bojesen A, et al. Mol Hum Reprod. 2010 Jun;16(6):396-401. doi: 10.1093/molehr/gaq016. Epub 2010 Mar 15. Mol Hum Reprod. 2010. PMID: 20231162 Review.